Upstage Lung Cancer

Using performing arts to raise awareness and funding for lung cancer research

Research We Fund

Upstage Lung Cancer is proud to have funded over $1 million in lung cancer research.

2018-2019: Early Detection

This grant was funded in part by Upstage Lung Cancer with MIT's Koch Institute Frontier Research Program

Sangeeta N. Bhatia, MD, PhD
Koch Institute


John J. and Dorothy Wilson Professor of Health Sciences and Technology and of Electrical Engineering and Computer Science, Massachusetts Institute of Technology

“Our laboratory conducts research at the intersection of engineering, medicine, and biology to develop novel platforms for understanding, diagnosing and treating cancer.”

Accurate, timely, and effective diagnosis is the first step in appropriately treating disease. At present, lung disease diagnoses require technologically-advanced imaging, due to a lack of a reliable circulating biomarker, and tumors are generally only detectable at relatively late stages of disease. A promising approach currently in development in the Bhatia lab is the introduction of synthetic biomarkers that interact with the diseased environment to produce a simple readout.